NCT01043406View on ClinicalTrials.gov

Seizure Advisory System Feasibility Study

PHASE1TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

October 31, 2012

Conditions
Epilepsy
Interventions
DEVICE

Seizure Advisory System

Implant of Seizure Advisory System followed by data collection for algorithm training and subsequent enabling of seizure advisory indicators.

Trial Locations (3)

3050

Royal Melbourne Hospital, Melbourne

3065

St. Vincent's Hospital (Melbourne), Melbourne

3081

Austin Health, Melbourne

Sponsors
All Listed Sponsors
lead

NeuroVista Corporation

INDUSTRY

NCT01043406 - Seizure Advisory System Feasibility Study | Biotech Hunter | Biotech Hunter